HI
NVO

Horizon Investments’s Novo Nordisk NVO Stock Holding History

Horizon Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Sell
50
-896
-95% -$38.5K ﹤0.01% 1258
2026
Q1 		$34.8K Buy
946
+780
+470% +$37K ﹤0.01% 1148
2025
Q4 		$8.45K Sell
166
-485
-75% -$24.8K ﹤0.01% 1174
2025
Q3 		$36.1K Sell
651
-5,723
-90% -$335K ﹤0.01% 1011
2025
Q2 		$440K Buy
6,374
+908
+17% +$61.8K 0.01% 827
2025
Q1 		$380K Buy
5,466
+2,952
+117% +$244K 0.01% 419
2024
Q4 		$216K Buy
2,514
+1,695
+207% +$183K 0.01% 526
2024
Q3 		$97.5K Buy
819
+32
+4% +$4.27K ﹤0.01% 622
2024
Q2 		$112K Buy
787
+40
+5% +$5.3K ﹤0.01% 620
2024
Q1 		$95.9K Sell
747
-67
-8% -$7.98K ﹤0.01% 614
2023
Q4 		$84.2K Sell
814
-286
-26% -$28.3K ﹤0.01% 603
2023
Q3 		$100K Sell
1,100
-142
-11% -$12.5K ﹤0.01% 608
2023
Q2 		$100K Buy
1,242
+70
+6% +$5.72K ﹤0.01% 606
2023
Q1 		$93.3K Buy
+1,172
New +$83.1K ﹤0.01% 606
2019
Q4 		– Sell
-129,054
Closed -$3.34M – 521
2019
Q3 		$3.34M Buy
+129,054
New +$3.26M 0.14% 72
2017
Q4 		– Sell
-56,998
Closed -$1.16M – 208
2017
Q3 		$1.16M Buy
56,998
+13,470
+31% +$304K 0.07% 79
2017
Q2 		$884K Sell
43,528
-934
-2% -$18.8K 0.05% 85
2017
Q1 		$762K Buy
44,462
+23,980
+117% +$418K 0.05% 87
2016
Q4 		$367K Buy
+20,482
New +$371K 0.03% 139

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Horizon Investments's NVO Position: Q2 2026 in Review

Horizon Investments reduced its Novo Nordisk (NVO) stake by 95% in Q2 2026, selling an estimated $38.5K and leaving 50 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Horizon Investments first reported a position in NVO in Q4 2016 and has held it in 19 quarters since. The position peaked at $3.34M in Q3 2019. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Horizon Investments held 50 shares of Novo Nordisk worth $2.4K as of Q2 2026.
  • Horizon Investments sold 896 Novo Nordisk shares in Q2 2026, an estimated $38.5K.
  • Novo Nordisk made up ﹤0.01% of Horizon Investments's portfolio in Q2 2026, its #1258 holding.
  • Horizon Investments first reported a position in Novo Nordisk in Q4 2016 and has held it in 19 quarters since.
  • Horizon Investments's Novo Nordisk position peaked at $3.34M in Q3 2019.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.